mRNA Cancer Vaccine Plus Keytruda Boosts Melanoma Survival
An mRNA cancer vaccine combined with Keytruda sharply improved survival in melanoma patients, UCHealth trial results show, advancing personalized neoantigen immunotherapy.
Topic
Topic
An mRNA cancer vaccine combined with Keytruda sharply improved survival in melanoma patients, UCHealth trial results show, advancing personalized neoantigen immunotherapy.